Locations

St. Louis, MO, USA · San Diego, CA, USA · Missouri City, MO, USA

industry

Biotechnology

Size

11 - 50 employees

Stage

Series C+

founded in

2018

Wugen is a clinical-stage biotechnology company developing the next generation of off-the-shelf memory natural killer (nk) and car-t cell therapies for cancer. Wugen is leveraging its proprietary moneta platform and deep genomic engineering expertise to pioneer a new class of memory nk cell therapies to treat hematological and solid tumor malignancies. Wugen is based out of st. Louis, missouri and san diego, california.

Something looks off?
Open jobs at Wugen

On-site & Remote